Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.

Tytuł:
Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
Autorzy:
Hasan MR; Department of Mathematics, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.; Department of Applied Mathematics, Faculty of Science, Noakhali Science and Technology University, Noakhali 3814, Bangladesh.
Alsaiari AA; College of Applied Medical Science, Clinical Laboratories Science Department, Taif University, Taif 21944, Saudi Arabia.
Fakhurji BZ; iGene Medical Training and Molecular Research Center, Jeddah 21589, Saudi Arabia.
Molla MHR; Department of Biological Sciences, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Asseri AH; Biochemistry Department, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.; Centre for Artificial Intelligence in Precision Medicines, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Sumon MAA; Department of Marine Biology, Faculty of Marine Sciences, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Park MN; College of Korean Medicine, Kyung Hee University, Hoigidong, Dongdaemungu, Seoul 02453, Korea.
Ahammad F; Department of Biological Sciences, Faculty of Science, King Abdul-Aziz University, Jeddah 21589, Saudi Arabia.
Kim B; College of Korean Medicine, Kyung Hee University, Hoigidong, Dongdaemungu, Seoul 02453, Korea.
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jun 29; Vol. 27 (13). Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, c1995-
MeSH Terms:
Drug Design*
Quantitative Structure-Activity Relationship*
Computer-Aided Design ; Drug Discovery/methods ; Molecular Docking Simulation ; Molecular Dynamics Simulation
References:
Curr Med Chem. 2001 Jul;8(9):1035-55. (PMID: 11472240)
Curr Med Chem. 2012;19(22):3763-78. (PMID: 22680930)
Comput Biol Med. 2021 Oct;137:104851. (PMID: 34520990)
Nat Rev Drug Discov. 2008 Jun;7(6):489-503. (PMID: 18511927)
Proteins. 2003 Jul 1;52(1):98-106. (PMID: 12784374)
Acta Pharmacol Sin. 2012 Sep;33(9):1131-40. (PMID: 22922346)
Molecules. 2015 Jul 22;20(7):13384-421. (PMID: 26205061)
Signal Transduct Target Ther. 2021 Jan 8;6(1):7. (PMID: 33414387)
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W526-31. (PMID: 15215442)
Nat Rev Drug Discov. 2018 May;17(5):333-352. (PMID: 29651105)
Bioinformatics. 2002 Sep;18(9):1250-6. (PMID: 12217917)
Front Pharmacol. 2017 Dec 04;8:889. (PMID: 29255418)
Sci Rep. 2021 Feb 18;11(1):4049. (PMID: 33603068)
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1479-1484. (PMID: 34734497)
BMC Bioinformatics. 2019 Sep 14;20(1):473. (PMID: 31521110)
J Biomed Sci. 2020 Jan 2;27(1):1. (PMID: 31894001)
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W223-8. (PMID: 18424800)
Chem Biodivers. 2006 Oct;3(10):1053-101. (PMID: 17193224)
Mol Divers. 2022 Jun;26(3):1893-1913. (PMID: 34686947)
J Mol Model. 2003 Feb;9(1):47-57. (PMID: 12638011)
J King Saud Univ Sci. 2021 Mar;33(2):101334. (PMID: 33432258)
Nat Rev Drug Discov. 2007 Jan;6(1):29-40. (PMID: 17159923)
RSC Adv. 2021 Dec 17;11(63):40120-40135. (PMID: 35494115)
J Chem Inf Model. 2005 Jan-Feb;45(1):160-9. (PMID: 15667141)
Electrophoresis. 1997 Dec;18(15):2714-23. (PMID: 9504803)
J Biomol Struct Dyn. 2022;40(22):11625-11637. (PMID: 34387135)
J Chem Inf Model. 2010 May 24;50(5):879-89. (PMID: 20415499)
J King Saud Univ Sci. 2021 Jan;33(1):101248. (PMID: 33250604)
J Mol Model. 2016 Oct;22(10):239. (PMID: 27638416)
Nat Protoc. 2021 Oct;16(10):4799-4832. (PMID: 34561691)
Clin Pharmacol Ther. 2010 Mar;87(3):272-7. (PMID: 20130567)
Methods Mol Biol. 2019;2053:149-167. (PMID: 31452104)
J Mol Graph Model. 2021 Mar;103:107803. (PMID: 33333424)
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8. (PMID: 15980494)
J Chem Inf Model. 2019 Jun 24;59(6):2509-2515. (PMID: 30946779)
Biopolymers. 2010 Jun;93(6):533-48. (PMID: 20095044)
Int J Mol Sci. 2010 Oct 08;11(10):3846-66. (PMID: 21152304)
Sci Rep. 2017 Jul 25;7(1):6359. (PMID: 28743970)
Compr Physiol. 2014 Jan;4(1):177-97. (PMID: 24692138)
Nat Methods. 2015 Jan;12(1):7-8. (PMID: 25549265)
Front Chem. 2020 Apr 28;8:343. (PMID: 32411671)
Front Pharmacol. 2020 Sep 29;11:01221. (PMID: 33117147)
Alcohol Res Health. 2008;31(1):49-59. (PMID: 23584751)
J Med Chem. 2011 Aug 11;54(15):5422-31. (PMID: 21692478)
Malar J. 2011 Jul 21;10:202. (PMID: 21777413)
Brief Bioinform. 2018 Nov 27;19(6):1382-1399. (PMID: 28981626)
Sci Rep. 2017 Mar 03;7:42717. (PMID: 28256516)
Front Pharmacol. 2018 Nov 13;9:1275. (PMID: 30524275)
Nat Rev Drug Discov. 2002 Jan;1(1):84-8. (PMID: 12119613)
Expert Opin Drug Discov. 2015 May;10(5):449-61. (PMID: 25835573)
J Math Biol. 2022 May 5;84(6):48. (PMID: 35508555)
Pharmaceuticals (Basel). 2022 May 23;15(5):. (PMID: 35631472)
Nature. 2021 Aug;596(7873):583-589. (PMID: 34265844)
J Med Chem. 2016 May 12;59(9):4035-61. (PMID: 26807648)
Environ Toxicol Pharmacol. 2020 Nov;80:103470. (PMID: 32814174)
Mutat Res. 2002 Jan 29;499(1):27-52. (PMID: 11804603)
Biotechnol Adv. 2015 Dec;33(8):1582-1614. (PMID: 26281720)
Drug Discov Today. 2020 Sep;25(9):1624-1638. (PMID: 32663517)
Br J Pharmacol. 2007 Sep;152(1):9-20. (PMID: 17549047)
Acta Pharmacol Sin. 2013 Aug;34(8):998-1006. (PMID: 23852086)
Int J Biol Macromol. 2022 Jul 31;213:1088-1097. (PMID: 35697166)
Iran J Pharm Res. 2017 Summer;16(3):910-923. (PMID: 29201082)
Methods Mol Biol. 2019;2053:189-202. (PMID: 31452106)
Molecules. 2021 Apr 20;26(8):. (PMID: 33923909)
Curr Top Med Chem. 2008;8(18):1555-72. (PMID: 19075767)
J Chem Inf Model. 2014 Jul 28;54(7):2068-78. (PMID: 24974889)
Molecules. 2021 Feb 01;26(3):. (PMID: 33535444)
J Chem Inf Model. 2008 Sep;48(9):1773-91. (PMID: 18763758)
Comb Chem High Throughput Screen. 2012 Dec;15(10):849-76. (PMID: 23140189)
Molecules. 2020 Mar 18;25(6):. (PMID: 32197324)
Nat Commun. 2022 May 18;13(1):2747. (PMID: 35585053)
Curr Top Med Chem. 2014;14(16):1923-38. (PMID: 25262799)
Adv Mater. 2017 Oct;29(37):. (PMID: 28752600)
AAPS J. 2012 Mar;14(1):133-41. (PMID: 22281989)
J Am Chem Soc. 2005 Aug 10;127(31):10967-76. (PMID: 16076203)
BMC Bioinformatics. 2014;15 Suppl 16:S7. (PMID: 25521245)
J Mol Graph Model. 2008 Sep;27(2):161-9. (PMID: 18485770)
Molecules. 2021 Oct 20;26(21):. (PMID: 34770739)
Nat Biotechnol. 2006 Dec;24(12):1565-7. (PMID: 17160063)
Br J Pharmacol. 2011 Mar;162(6):1239-49. (PMID: 21091654)
J Chem Inf Model. 2011 Jun 27;51(6):1307-14. (PMID: 21604800)
Evid Based Complement Alternat Med. 2022 May 13;2022:1679589. (PMID: 35600940)
J Chem Inf Model. 2012 Oct 22;52(10):2587-98. (PMID: 22970894)
Molecules. 2018 Jul 30;23(8):. (PMID: 30061498)
Chem Biol. 2001 May;8(5):445-57. (PMID: 11358692)
Molecules. 2015 Dec 19;20(12):22799-832. (PMID: 26703541)
Biochem Soc Trans. 2003 Jun;31(Pt 3):611-4. (PMID: 12773166)
Chem Biol Drug Des. 2006 May;67(5):370-2. (PMID: 16784462)
Comput Struct Biotechnol J. 2022 Jun 03;20:2831-2838. (PMID: 35765652)
Front Microbiol. 2016 Jul 22;7:1131. (PMID: 27499750)
Hepatology. 2013 Mar;57(3):873-4. (PMID: 23456678)
J Biomol Struct Dyn. 2022 Jan;40(1):14-30. (PMID: 32677533)
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W39-43. (PMID: 15980496)
Nat Rev Genet. 2020 Jun;21(6):339-354. (PMID: 32060427)
J Mol Model. 2011 Jan;17(1):201-8. (PMID: 20383726)
Mar Drugs. 2021 Apr 28;19(5):. (PMID: 33925208)
Bioinformatics. 2018 Jul 15;34(14):2508-2509. (PMID: 29522123)
Nucleic Acids Res. 2007;35(10):3375-82. (PMID: 17478507)
Int J Mol Sci. 2010 Aug 18;11(8):3016-34. (PMID: 21152288)
Trends Pharmacol Sci. 2022 Feb;43(2):136-150. (PMID: 34895945)
Heliyon. 2018 Nov 23;4(11):e00938. (PMID: 30519653)
Comput Math Methods Med. 2015;2015:418767. (PMID: 25784957)
Theriogenology. 2010 Jun;73(9):1167-79. (PMID: 20138353)
Nat Protoc. 2012 Jul 19;7(8):1511-22. (PMID: 22814390)
Arch Pharm Res. 2015 Sep;38(9):1686-701. (PMID: 26208641)
Drug Discov Today. 2001 Apr 1;6(7):357-366. (PMID: 11267922)
J Mol Recognit. 1996 Jan-Feb;9(1):1-5. (PMID: 8723313)
Front Bioeng Biotechnol. 2021 Jul 29;9:691152. (PMID: 34395399)
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. (PMID: 33510482)
Annu Rev Biophys. 2008;37:289-316. (PMID: 18573083)
Brief Bioinform. 2021 Sep 2;22(5):. (PMID: 33834183)
Metabolomics. 2017;13(1):9. (PMID: 28058041)
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):439-44. (PMID: 24367073)
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7. (PMID: 15980490)
Sci Rep. 2022 Jun 16;12(1):10062. (PMID: 35710559)
J Cheminform. 2018 Jun 26;10(1):29. (PMID: 29943074)
Front Pharmacol. 2020 Feb 26;11:119. (PMID: 32174833)
Grant Information:
27302C0038 United States ES NIEHS NIH HHS
Contributed Indexing:
Keywords: CADD; MD simulation; MM-GBSA; MM-PBSA; QSAR; biological activity; drug design; mathematical modeling; pharmacophore modeling
Entry Date(s):
Date Created: 20220709 Date Completed: 20220712 Latest Revision: 20231101
Update Code:
20240105
PubMed Central ID:
PMC9268380
DOI:
10.3390/molecules27134169
PMID:
35807415
Czasopismo naukowe
The conventional drug discovery approach is an expensive and time-consuming process, but its limitations have been overcome with the help of mathematical modeling and computational drug design approaches. Previously, finding a small molecular candidate as a drug against a disease was very costly and required a long time to screen a compound against a specific target. The development of novel targets and small molecular candidates against different diseases including emerging and reemerging diseases remains a major concern and necessitates the development of novel therapeutic targets as well as drug candidates as early as possible. In this regard, computational and mathematical modeling approaches for drug development are advantageous due to their fastest predictive ability and cost-effectiveness features. Computer-aided drug design (CADD) techniques utilize different computer programs as well as mathematics formulas to comprehend the interaction of a target and drugs. Traditional methods to determine small-molecule candidates as a drug have several limitations, but CADD utilizes novel methods that require little time and accurately predict a compound against a specific disease with minimal cost. Therefore, this review aims to provide a brief insight into the mathematical modeling and computational approaches for identifying a novel target and small molecular candidates for curing a specific disease. The comprehensive review mainly focuses on biological target prediction, structure-based and ligand-based drug design methods, molecular docking, virtual screening, pharmacophore modeling, quantitative structure-activity relationship (QSAR) models, molecular dynamics simulation, and MM-GBSA/MM-PBSA approaches along with valuable database resources and tools for identifying novel targets and therapeutics against a disease. This review will help researchers in a way that may open the road for the development of effective drugs and preventative measures against a disease in the future as early as possible.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies